相关实验视频

Updated: Jan 18, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

瘤基因驱动性NSCLC中介素-1β表达的预后意义和新兴预测潜力

Mengni Guo¹, Won Jin Jeon¹, Bowon Joung¹

¹Division of Hematology and Oncology, Loma Linda University, Loma Linda, CA 92354, USA.

|September 13, 2025

概括

介素-1β (IL-1β) 表达影响非小细胞肺癌 (NSCLC) 的存活率,特别是在EGFR或ALK改变的瘤中. 较低的IL-1β与NSCLC的更好的结果相关,这表明向治疗可能有利于特定的分子子集.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症基因组学癌症基因组学

背景情况:

临床前数据表明,互白素-1β (IL-1β) 影响非小细胞肺癌 (NSCLC) 瘤行为.
调查NSCLC中IL-1β抑制的临床试验产生了不同的结果,强调需要了解其在特定分子亚型中的作用.

研究的目的:

评估IL-1β表达在NSCLC在各种分子亚型中的预后和预测意义.
确定IL-1β表达水平是否与不同NSCLC遗传特征的生存结果和治疗反应相关.

主要方法:

使用下一代DNA和RNA测序对21,698个NSCLC瘤的分析.
将IL-1β表达的分层分为四分位数,并使用保险索赔数据评估现实世界的整体存活率 (OS) 和治疗时间 (TOT).
包括考克斯模型在内的统计分析,以评估与IL-1β表达和分子变化相关的生存结果.

主要成果:

较低的IL-1β表达 (Q1) 与较高表达 (Q4) 相比,在未选择的NSCLC患者中与较长的生存期有关.
这种预后效应在EGFR突变腺癌和ALK融合阳性NSCLC中更为明显.
高IL-1β表达与KRAS突变腺癌免疫治疗时间长相关,并与TP53突变,高瘤突变负担 (TMB) 和PD-L1表达相关.

结论:

IL-1β表达作为NSCLC的潜在预后和预测生物标志物,在特定的分子子集中具有显著的关联.
针对IL-1β的治疗策略对EGFR或ALK变异NSCLC患者可能特别有前途.
对IL-1β在NSCLC病原和治疗反应中的作用进行进一步研究是有必要的.

关键词:

阿尔克 (ALK) 是一个欧洲农业基金会 (EGFR) 是一个.克拉斯 (Kras) 是一个国家.在NSCLCLC中,我们可以看到.介质素-1ββ的使用情况.致癌突变致癌突变致癌突变生存结果的结果.瘤微环境是一个微环境.

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...